This observation is important for docs to guide them where they should test for the oncogene. It does not change the overall no of patients who should have a better therapeutic outcome from treatment with crizotinib.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.